Related Experiment Videos
Truncated BRCA2 is cytoplasmic: implications for cancer-linked mutations
B H Spain1, C J Larson, L S Shihabuddin
1Laboratory of Genetics, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.
Summary
Most BRCA2 mutations lead to nonfunctional proteins because they prevent the protein from entering the cell nucleus. This occurs because critical nuclear localization signals are located in the C-terminal region of BRCA2.
Area of Science:
- Genetics
- Molecular Biology
- Cancer Research
Background:
- BRCA2 mutations are primarily linked to breast cancer predisposition.
- The majority of BRCA2 mutations result in truncated, nonfunctional proteins.
- Even small deletions in BRCA2 suggest the importance of its C-terminal residues.
Purpose of the Study:
- To investigate the functional consequences of BRCA2 mutations.
- To identify the region of BRCA2 responsible for nuclear localization.
- To explain why most BRCA2 mutants are nonfunctional.
Main Methods:
- Utilized green fluorescent protein (GFP)-tagged BRCA2 deletion mutants.
- Assessed the subcellular localization of wild-type and mutant BRCA2 proteins.
- Examined an endogenous truncated BRCA2 mutant (6174delT).
Main Results:
- Nuclear localization of BRCA2 is dependent on two nuclear localization signals within the final 156 residues.
- A truncated BRCA2 mutant (6174delT) was observed in the cytoplasm.
- These findings indicate that C-terminal deletions disrupt nuclear translocation.
Conclusions:
- The C-terminal region of BRCA2 is essential for its nuclear localization.
- Disruption of nuclear localization is a primary mechanism for BRCA2 dysfunction in cancer.
- Understanding these mechanisms can inform cancer risk assessment and therapeutic strategies.